Journal article

RAGE deficiency predisposes mice to virus-induced paucigranulocytic asthma

J Arikkatt, MA Ullah, KR Short, V Zhang, WJ Gan, Z Loh, RB Werder, J Simpson, PD Sly, SB Mazzone, KM Spann, MAR Ferreira, JW Upham, MB Sukkar, S Phipps

Elife | ELIFE SCIENCES PUBLICATIONS LTD | Published : 2017

Open access

Abstract

Asthma is a chronic inflammatory disease. Although many patients with asthma develop type-2 dominated eosinophilic inflammation, a number of individuals develop paucigranulocytic asthma, which occurs in the absence of eosinophilia or neutrophilia. The aetiology of paucigranulocytic asthma is unknown. However, both respiratory syncytial virus (RSV) infection and mutations in the receptor for advanced glycation endproducts (RAGE) are risk factors for asthma development. Here, we show that RAGE deficiency impairs anti-viral immunity during an early-life infection with pneumonia virus of mice (PVM; a murine analogue of RSV). The elevated viral load was associated with the release of high mobilit..

View full abstract

Grants

Awarded by Wellcome Trust


Funding Acknowledgements

National Health and Medical Research Council 1054081 Kirsty Renfree ShortNational Health and Medical Research Council 1023756 John WU pham Simon PhippsAustralian Infectious Disease Research Excellence Award Simon PhippsAustralian Research Council Simon PhippsRebecca L.Cooper Medical Research Foundation Simon PhippsThe funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.